Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02512627
Other study ID # 103-6651A3
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 30, 2015
Est. completion date March 13, 2019

Study information

Verified date May 2019
Source Chang Gung Memorial Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aims to investigate and compare the intervention effects of combining exercise and cognitive training (either sequentially or simultaneously in a dual-task paradigm) in elderly with mild cognitive impairment. The investigators hypothesize that (1) both sequential and dual-task training can induce greater improvements in the outcome measures than single mode of training; (2) the improvement in cognitive functions and other outcomes may differ between the groups.


Description:

Background and study aims:

Mild cognitive impairment (MCI) or minor neurocognitive disorder is a syndrome defined as an intermediate stage between cognitively intact and clinically diagnosed dementia. The age-adjusted prevalence of MCI in Taiwan is approximately 18%, while women have higher prevalence for MCI than men. The progression rate from MCI to dementia ranges from 10 to 15% each year, and over 50% of the MCI population will develop into severe cognitive impairment or dementia in 5 years. Therefore, early detection of the individuals who manifest MCI and provide appropriate interventions may help reduce the burden of their caregivers and the medical expenses of the health-care system. Previous studies found that cognitive training or exercise has emerged as an important therapeutic approach for individuals with MCI. However, the intervention effects of combining exercise and cognitive training remain to be determined. Furthermore, whether exercise and cognitive training should be administered in sequential order or simultaneously is an important question to pursue. The overall goal of this study is to determine and compare the intervention effects cognitive training, exercise, and combining cognitive and exercise training in individuals with MCI.

Who can participate? Individuals with MCI.

What does the study involve? The participants will receive a total of 36 training sessions, and each session will contain 90 minutes of training. Training frequency will be 2-3 times per week for 12-18 weeks. All participants will received pretreatment test, post treatment test, and a 6-month follow-up test.

What are the possible benefits and risks of participating? The possible benefits include improvement in cognitive, physical, and daily functions. There are no risks for participating.

Where to conduct the study? The investigators anticipate recruiting a total of 80 participants from geriatric day care centers and nursing homes from multiple cities in Taiwan.


Recruitment information / eligibility

Status Completed
Enrollment 55
Est. completion date March 13, 2019
Est. primary completion date January 29, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years and older
Eligibility Inclusion Criteria:

1. able to follow instruction,

2. clinical dementia rating (CDR) = 0.5 or 1,

3. self- or informant-reported memory or cognitive complaint, and

4. able to perform activities of daily living (Barthel Index = 70).

Exclusion Criteria:

1. recent myocardial infarction,

2. heart failure,

3. recent heart surgery,

4. severe asthma,

5. concomitant with other neurological disorders, or

6. joint deformity that might prevents them performing exercise or cognitive training.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Cognitive training
visuospatial, attention, memory, and executive abilities
Physical exercise
endurance, balance, and mobility

Locations

Country Name City State
Taiwan Baliexcelsior Nursing Home?? New Taipei City
Taiwan Pine nursing home Taichung
Taiwan Bailing clinics and nursing homes Taipei
Taiwan Shihlin cum day care center Taipei
Taiwan TaoSheng Nursing home Taipei
Taiwan Xihu day care center Taipei
Taiwan Zhishan community home Taipei
Taiwan Chang Gung Memorial Hospital Taoyuan
Taiwan Chang Gung Memorial Hospital Taoyuan Branch Taoyuan

Sponsors (1)

Lead Sponsor Collaborator
Chang Gung Memorial Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change scores of Montreal Cognitive Assessment (MoCA) The MoCA will be used to assess general cognitive functions. It examines several cognitive domains with a total score of 30. baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Primary Change scores of Stroop test The Stroop test will be used to assess the processing speed, inhibition, set-shifting, and selective attention abilities. The participants will be tested under 2 conditions: congruent and incongruent conditions. In the congruent condition, the color ink of a word is consistent with the written color name; while the color ink differs from the written color name under the incongruent condition. baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Primary Change scores of Dual-task test The dual-task tests will be assessed to determine the ability for an individual to perform 2 tasks simultaneously. The investigators will assess the dual-task performance during walking and performing box and block test. The results of the dual-task tests will provide information regarding to whether the 2 tasks compete for the same class of neural resources or one of the tasks can be carried out automatically. baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Primary Change scores of Timed up and go (TUG) test The TUG test will be used to assess the mobility and dynamic balance ability. The participants will be required to stand up from a chair, walk 3 meters, turn around, then walk back to the chair, and sit down. The time to complete the TUG test has been shown to be a good indicator to detect potential fallers and frail elderly (Podsiadlo & Richardson, 1991). The test-retest reliability of TUG on individuals with cognitive impairment was excellent (Blankevoort, van Heuvelen, & Scherder, 2013). baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Secondary Change scores of the Verbal Fluency Test Verbal fluency tests will be used to evaluate the semantic memory of the participants. The participants will be instructed to say as many words as possible from a given category (i.e., fruit or animal) in 1 minute. The validity, reliability, and normative performance of verbal fluency tests have been well-established (Harrison, Buxton, Husain, & Wise, 2000). baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Secondary Change scores of the Useful Field of View (UFOV) Useful field of view (UFOV) is the visual area over which useful information could be obtained at a quick glance without eye or head movements. This UFOV will be assessed with the BrainHQ program. The UFOV will assess the abilities of visuomotor processing speed, divided attention, and selective attention (Ball, Edwards, & Ross, 2007). baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Secondary Change scores of the 30 second chair stand test (CST) The 30 second chair stand test (CST) will be assessed to indicate the strength and endurance level of the lower extremities. The participants will be asked to stand up from a standardized chair and then sit down as many times as possible within 30 seconds. The feasibility and reliability of using CST in people with cognitive impairment have been established to be good (Blankevoort et al., 2013). baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Secondary Change scores of the Chinese version of the International Physical Activity Questionnaires (IPAQ) The Chinese version of the International Physical Activity Questionnaires (IPAQ) is an international measure for health-related physical activity. A short form of IPAQ will be used to assess changes in physical activity before and after intervention in this study. The reliability and validity of IPAQ has been established across 12 countries (Craig et al., 2003). baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Secondary Change scores of the Barthel Index (BI) Assess activities of daily living baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Secondary Change scores of the Lawton Instrumental Activities of Daily Living Scale Assess activities of daily living. baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Secondary Change scores of the Disability Assessment for Dementia (DAD) Assess activities of daily living. baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Secondary Change scores of the Quality of Life in Alzheimer's Disease Instrument (QoLAD) The Chinese version of QoLAD will be used. baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Secondary Change scores of the Caregiver Burden Inventory (CBI) The Chinese version of CBI will be used. baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Secondary Change scores of the Geriatric Depression Scale (GDS) The Chinese version of short form GDS will be used. baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Secondary Change scores of the Community Integration Questionnaire (CIQ) The CIQ measures items relevant to home integration, social integration, and productive activities. baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Secondary Change scores of the ActiGraph GX3 accelerometers Change scores of the ActiGraph The actigraphy will be placed on the waist for a 3-day period immediately before and after the intervention. The participants will wear the actigraphy during all daily activities except for those that involve water (i.e., showering or swimming). baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Secondary Change scores of evaluating isometric knee flexors and extensors muscle strength The participant will be seated upright in a chair with back support, the knee will be placed in 90-degree flexion and the evaluator will stabilize the thing to eliminate synergistic movements. Participants will be asked to perform a maximal isometric contraction of knee flexion and extension with both lower extremities. The investigators will record the mean value of 3 attempts. baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Secondary Change scores of using hand dynamometer to measure grip strength of both hand The participant is seated, with the elbow at 90-degree flexion. The investigators will record the mean value of 3 attempts. baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Secondary Change scores of Wechsler Memory Scale - Third Edition (WMS-III) The investigators will use the WMS-III subtests, including Faces Recognition (score range 0-48), Verbal Paired Associates (score range 0-32), Word Lists (0-48), and Spatial Span (0-32) to assess the immediate, delayed, and working memory tests. Higher scores indicated better performance for each subtest. The raw score of each subtest will also be transferred to standardized Z scores and summed to represent an index of general memory function. baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Secondary Change scores of Wechsler Adult Intelligence Scale - Third Edition (WAIS-III) The WAIS-III includes tests that evaluate cognitive functions in verbal comprehension, working memory, perceptual organization, and processing speed. The subtests that the investigators will use are the Digit Symbol-Coding (scores range 0-133) and Matrix Reasoning tests (0-26). The raw score of each subtest will also be transferred to standardized Z scores and summed to represent an index of general cognitive function. baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Secondary BDNF val66met genotype Saliva samples will be collected at baseline to determine the Brain-Derived Neurotrophic Factor (BDNF) val66met genotype. baseline
See also
  Status Clinical Trial Phase
Completed NCT04513106 - Promoting Advance Care Planning for Persons With Early-stage Dementia in the Community: a Feasibility Trial N/A
Recruiting NCT06011681 - The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
Recruiting NCT04522739 - Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease Phase 4
Active, not recruiting NCT03167840 - Falls Prevention Through Physical And Cognitive Training in Mild Cognitive Impairment N/A
Active, not recruiting NCT03676881 - Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
Not yet recruiting NCT05041790 - A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment Phase 4
Recruiting NCT04121156 - High Definition Transcranial Direct Current Stimulation (HD-tDCS) in Patients With Mild Cognitive Impairment N/A
Recruiting NCT03605381 - MORbidity PRevalence Estimate In StrokE
Completed NCT02774083 - Cognitive Training Using Feuerstein Instrumental Enrichment N/A
Completed NCT01315639 - New Biomarker for Alzheimer's Disease Diagnostic N/A
Enrolling by invitation NCT06023446 - Can (Optical Coherence Tomography) Pictures of the Retina Detect Alzheimer's Disease at Its Earliest Stages?
Completed NCT04567745 - Automated Retinal Image Analysis System (EyeQuant) for Computation of Vascular Biomarkers Phase 1
Recruiting NCT05579236 - Cortical Disarray Measurement in Mild Cognitive Impairment and Alzheimer's Disease
Completed NCT03583879 - Using Gait Robotics to Improve Symptoms of Parkinson's Disease N/A
Terminated NCT02503501 - Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease Phase 2
Not yet recruiting NCT03740178 - Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005) Phase 1
Active, not recruiting NCT05204940 - Longitudinal Observational Biomarker Study
Recruiting NCT02663531 - Retinal Neuro-vascular Coupling in Patients With Neurodegenerative Disease N/A
Recruiting NCT06150352 - Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
Recruiting NCT03507192 - Effects of Muscle Relaxation on Cognitive Function in Patients With Mild Cognitive Impairment and Early Stage Dementia. N/A